reports
- Mariam Wael
- Merna Arafat
Egypt Pharma 2022: Well positioned for recovery, supported by favorabl...
Egypt is the MEA region’s largest producer and second largest consumer of pharmaceuticals, growing at a CAGR of 17% over 2013a-2020a, surpassing the region’s CAGR of 8%. Despite pressure during the past couple of years because of the pandemic, we forecast total pharma market to grow at a 6-year CAGR of 13.2% between 2021e -26f. During 2022f, we expect the retail pharma market to record sales of EGP95.2 billion (+10.1% YoY), while non-retail pharma sales record EGP48.0 billion (+13.4% YoY), br...
- Mariam Wael
- Merna Arafat
Egypt Pharma 2021: Not entirely defensive; Macro dynamics to support g...
Egypt is the MEA region’s largest producer and second-largest consumer of pharmaceuticals, growing by a CAGR (2013-2019) of 19%, surpassing the region’s CAGR of 8%. Market growth is predominantly driven by out of the pocket expenditure (61% of total health expenditure), alongside a heavily growing population by c.2% per annum. Yet, Egypt still exhibits one of the lowest pharma expenditure per capita figures in the MENA region, implying vast room for future growth. We forecast the total pharma...
- Mohamed Antar
Egypt small cap pharma | Initiate with Overweight ratings on Alexandri...
Cheap plays in a high growth market. Generics control c33% of Egypt’s pharma market, and due to the country’s low drug purchasing power (cUSD30 per capita in 2017), we expect this segment to outpace broader market growth (at a 2017-2021 CAGR of 23%, reaching 43% of the market by 2021). Expectations that the Ministry of Health will opt for gradual price deregulation also allow for superior growth. The MoH most recently approved price hikes in May 2016 (20% for all drugs priced less than EGP30/uni...
Ford Equity International Rating and Forecast Report
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.